Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind over shoulder: can imagery training ease chronic pain?

NCT ID NCT06092502

Symptom relief Sponsor: Nuray Alaca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial investigates whether adding graded motor imagery (GMI) therapy—a sequence of left/right discrimination, mental imagery, and mirror therapy—to standard physiotherapy can improve pain, movement, and function in people with shoulder impingement syndrome. Thirty adults aged 20–50 with shoulder pain lasting more than six weeks will be randomly assigned to receive either standard physiotherapy alone or standard physiotherapy plus GMI. The study measures pain levels, shoulder disability, range of motion, and changes in pain-related fear and central nervous system sensitivity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
graded motor imagery therapy (left/right discrimination, explicit motor imagery, and mirror therapy) added to a traditional physiotherapy program
What this could lead to
If effective, this approach could offer a better way to treat shoulder impingement syndrome by addressing both physical and brain-based aspects of pain.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply widely. The therapy requires effort and flexibility, and its benefits over standard care alone are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Oct 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 20-50 years of age with complaints of shoulder pain in the anterio-lateral region lasting more than 6 weeks, with a positive Neer impingement test and/or a positive Hawkins-Kennedy test * Additionally, patients must have at least one of the symptoms listed. These symptoms are: painful arch on active shoulder elevation, pain with resisted shoulder external rotation in abduction at 90°, and a positive empty can test. Exclusion Criteria: * Having had a steroid injection into the shoulder within the last 3 months * Previous surgery on the neck, thoracic spine or shoulder * Red flags (e.g. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis, resting blood pressure greater than 140/90 mmHg, history of long-term steroid use) * History of shoulder dislocation, subluxation, fracture, adhesive capsulitis, frozen shoulder, or cervical or thoracic surgery * History of full-thickness rotator cuff tear * History of cervical disc herniation in the last 6 weeks * History of breast cancer on the involved side * Isolated acromioclavicular joint pathology (i.e., pain directly localized over the acromioclavicular joint). * Signs of cervical radiculopathy, radiculitis, or referred pain originating from the cervical spine * Receiving treatment for shoulder pain in the last 3 months * Being currently pregnant (Dunning, 2022) * Scoring ≤24 on the Standardized Mini Mental Test was determined.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shoulder impingement syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

shoulder impingement syndrome Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Shoulder impingement syndrome Shoulder pain

Contacts and locations

Locations

  • Nuray ALACA

    Istanbul, Turkey, +90, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.